Moreover, human gliomas display a stemness signature, and SHH-GLI signaling regulates the expression of stemness genes (e.g. Nanog, Oct4, Sox2, CD133) and the self-renewal of CD133(+) glioma cancer stem cells10,11. The gene discussed is SOX2; the disease is central nervous system cancer.